ABCD of the phosphodiesterase family: interaction and differential activity in COPD
about
Compartmentalized cyclic adenosine 3',5'-monophosphate at the plasma membrane clusters PDE3A and cystic fibrosis transmembrane conductance regulator into microdomains.Defining the role of a FYVE domain in the localization and activity of a cAMP phosphodiesterase implicated in osmoregulation in Trypanosoma cruzi.Phosphodiesterase sequence variants may predispose to prostate cancer.Sildenafil Can Affect Innate and Adaptive Immune System in Both Experimental Animals and Patients.Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary diseaseRoflumilast: a novel treatment for chronic obstructive pulmonary disease.New methods for the discovery and synthesis of PDE7 inhibitors as new drugs for neurological and inflammatory disorders.Multiple facets of cAMP signalling and physiological impact: cAMP compartmentalization in the lung.PDE inhibitors currently in early clinical trials for the treatment of asthma.Roles of roflumilast, a selective phosphodiesterase 4 inhibitor, in airway diseases.Pyridazinone: an attractive lead for anti-inflammatory and analgesic drug discovery.Emerging Therapeutic Options for the Management of COPD.Population pharmacokinetic modelling of roflumilast and roflumilast N-oxide by total phosphodiesterase-4 inhibitory activity and development of a population pharmacodynamic-adverse event model.Cyclic nucleotide phosphodiesterase-1C (PDE1C) drives cell proliferation, migration and invasion in glioblastoma multiforme cells in vitro.Orally Available Soluble Epoxide Hydrolase/Phosphodiesterase 4 Dual Inhibitor Treats Inflammatory Pain.
P2860
Q33721181-8CC58A6D-BC5A-48A4-A619-5465B842E4FBQ34667038-E5DEE986-7E48-4260-BC67-B108DFFF1AB1Q35843428-6D78144A-1663-4B00-9E9B-D1354D90C738Q37681576-124B49D6-BCA5-4452-8C19-9DD6D1C200B9Q37828179-7871ACCE-4425-4464-AB0A-21377507F4B7Q37995404-1E7B3B4C-1E21-46C6-BEDB-34C203018352Q38097492-0F65F05A-85F9-4129-A98E-3587592D277CQ38166604-72D8856C-A8DA-46AF-918F-77BBEC0F5254Q38215280-FB6CFE1A-BA48-420B-B87C-EE54BED060AAQ38681962-12F52ACC-35E4-4AB1-B7EB-0D5831CB548EQ38783636-A2D2E4CC-A5AD-44D3-94A8-5EE0A6C377B2Q39936577-425235F9-5344-4A0A-B609-9C369A1214D2Q42944304-E1FE1416-E164-4BCA-9C68-6BEB4D1327E6Q48360844-9A776E49-FB66-40A9-B85F-C7BA2BFF9586Q52610098-284F91FF-B642-4126-AFCB-0C5AC04A42A9
P2860
ABCD of the phosphodiesterase family: interaction and differential activity in COPD
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
ABCD of the phosphodiesterase family: interaction and differential activity in COPD
@ast
ABCD of the phosphodiesterase family: interaction and differential activity in COPD
@en
ABCD of the phosphodiesterase family: interaction and differential activity in COPD
@nl
type
label
ABCD of the phosphodiesterase family: interaction and differential activity in COPD
@ast
ABCD of the phosphodiesterase family: interaction and differential activity in COPD
@en
ABCD of the phosphodiesterase family: interaction and differential activity in COPD
@nl
prefLabel
ABCD of the phosphodiesterase family: interaction and differential activity in COPD
@ast
ABCD of the phosphodiesterase family: interaction and differential activity in COPD
@en
ABCD of the phosphodiesterase family: interaction and differential activity in COPD
@nl
P2860
P921
P356
P1476
ABCD of the phosphodiesterase family: interaction and differential activity in COPD
@en
P2093
David M G Halpin
P2860
P304
P356
10.2147/COPD.S1761
P407
P577
2008-01-01T00:00:00Z